Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 81.93
-1.41 (-1.69%)
At close: Nov 11, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 18.72 billion as of November 11, 2025. Its market cap has increased by 100.76% in one year.
Market Cap
18.72B
Enterprise Value
20.61B
Revenue
13.30B
Ranking
n/a
PE Ratio
20.95
Stock Price
81.93
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 18.72B, an increase of 161.99%. That is a compound annual growth rate of 24.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 18.72B | 20.29% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 126.87B |
| Abbott Laboratories (Pakistan) | 108.02B |
| The Searle Company | 64.26B |
| Highnoon Laboratories | 58.62B |
| AGP Limited | 54.63B |
| Shifa International Hospitals | 32.30B |
| Ferozsons Laboratories | 17.38B |
| Macter International | 16.52B |